ÂÜÀòÂÒÂ×

Jim Lund is an accomplished bioinformatician specializing in next generation sequencing (NGS) applications in oncology and common diseases. Currently serving as the Director of Bioinformatics at XenoSTART, Jim has extensive experience in developing molecular oncology products and integrating clinical testing systems. With a Ph.D. in Physiology from The Johns Hopkins University School of Medicine and ten years of research focused on the biology of aging, Jim has pioneered genomic studies, managed significant research groups, and led various initiatives in both academic and industry settings, including roles at WuXi NextCODE and Stanford University.